Hypo-METRICS: Hypoglycaemia - Measurement, ThResholds and ImpaCtS;A clinical study to Determine the Optimal Threshold and duration of low interstitial glucose events that have an impact on patient experienced hypoglycaemia, quality of life and health economic outcomes.
- Conditions
- Diabetes mellitus''sugar disease''10018424
- Registration Number
- NL-OMON49518
- Lead Sponsor
- Radboud Universitair Medisch Centrum
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 75
1. Age 18 - 85 years
2. HbA1c 5 * 10% [31 * 86 mmol/mol]
3. Confirmed diagnosis of type 1 or type 2 diabetes
4. Using > 1 injection of insulin / day or insulin pump.
5. Ability to provide written informed consent
6. Performing regular SMBG [ > 1 / day on a 4-week download] . For those using
flash or continuous glucose monitoring, this should be used at least 70% of the
time.
7. At least 1 episode of hypoglycaemia [ either biochemical or symptomatic] in
the last month
8. On stable therapy for at least 3 months.
9. Willing to complete study procedures including wearing the Fitbit and CGM
devices and completing the EMA questionnaires on the uMotif app three times a
day for 10 weeks ( we expect minimum 80% data completeness)
1. Concurrent conditions that can affect glucose readings [renal impairment GFR
< 30 ml/min, hepatic impairment, untreated adrenal or thyroid insufficiency, as
judged by the investigator.
2. Severe cognitive impairment or psychological illness that can impair
performance of EMA tasks, visual impairment that will preclude use of the EMA
or sensors.
3. Severe psychiatric / psychological illness including extreme fear of hypo-
or hyper- glycaemia ( in the opinion of the investigator)
4. Pregnant or plans for pregnancy in the next 6 months
5. Use of automated insulin delivery systems such as closed loop or automated
threshold suspend or predictive low glucose suspend insulin pumps.
6. Known allergies to adhesives required for the CGM systems
7. People who work regular night shifts
8. Any other condition which in the opinion of the study team would impair
their ability to complete the study
Study & Design
- Study Type
- Observational invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>Determine the Low Interstitial Glucose (LIG) parameters that have the optimum<br /><br>performance for detection and identification of patient-reported-hypoglycemia<br /><br>(PRH); *LIG*_PRH (h_opt,t_opt).</p><br>
- Secondary Outcome Measures
Name Time Method <p>Impact of symptomatic and asymptomatic hypoglycaemia on different domains of<br /><br>Quality of Life (QoL) and health economic variables. </p><br>